Nicolas Mayer‑Rossignol announces the return of his bladder cancer and assures that he will continue to carry out his duties

Rouen – 30 June 2026: The mayor of Rouen, Nicolas Mayer‑Rossignol (Socialist Party), has publicly announced that he has been diagnosed with a new bladder tumor. In a statement published on 29 June, Mayer‑Rossignol said that he has already undergone surgery again and is in stable condition. He promises to continue his official duties and to be open about his state of health.

According to the statement, the most recent surgical procedure took place on 9 June; the mayor was discharged from hospital on 13 June. Local media and the Rouen city administration reported that suspicious findings had been noticed at the end of April, leading to further examinations. In his letter, Mayer‑Rossignol refers to the recurring nature of the condition: the first diagnosis dates back to 2022, and several procedures and treatments have taken place since then.

The 41-year-old politician had already gone public with the diagnosis in 2024; at the time, he explained that he had been receiving treatment for a bladder tumor since 2022. His new diagnosis comes at a time when he remains politically active: Mayer‑Rossignol was confirmed in office by the city council in March 2026 and has led the municipal majority since then. In his statement, he stressed that he will continue to fulfill his responsibilities as an elected representative.

For superficial bladder tumors, repeated check-ups, procedures and, in some cases, additional therapies are medically common; the course can be marked by recurrences. In his communiqué, Mayer‑Rossignol announces additional examinations planned for October to assess the risk of progression and determine further management. He thanked family members and medical staff for their support.

Politically, the news is being received soberly in Rouen and the Rouen‑Normandie metropolitan area: both city authorities and local media reported on the mayor’s situation and referred to his commitment not to neglect his official duties. At the same time, the city administration confirmed routine procedures and replacement arrangements for short-term absences.

The statement follows several months in which Mayer‑Rossignol has been politically visible, most recently through activities related to the municipal agenda and public engagements. Observers emphasize that openness about health issues is increasingly expected in France when they may affect the ability of elected officials to act.

For citizens and political partners, it remains crucial that medical information is communicated accurately and promptly; Mayer‑Rossignol has pledged transparency and announced that he will continue to provide updates on further findings and decisions.